Realm Therapeutics Announces 2018 Annual Report Available and Form 20-F Filing PR Newswire MALVERN, Pa., April 10, 2019 MALVERN, Pa., April 10, 2019 /PRNewswire/ -- Realm Therapeutics plc...
Realm Therapeutics Announces Receipt of Nasdaq Listing Determination and Requests Hearing PR Newswire MALVERN, Pa., April 5, 2019 MALVERN, Pa., April 5, 2019 /PRNewswire/ -- Realm Therapeutics...
Realm Therapeutics Announces Completion of Assets Disposal PR Newswire MALVERN, Pa., March 29, 2019 MALVERN, Pa., March 29, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM) today...
Realm Therapeutics Announces Cancellation of AIM Listing PR Newswire MALVERN, Pa., March 26, 2019 MALVERN, Pa., March 26, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a...
Realm Therapeutics Announces Result of General Meeting All Resolutions Passed Reminder: Process to Convert Ordinary Shares into ADSs PR Newswire MALVERN, Pa., March 15, 2019 MALVERN, Pa., March...
Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company"), Update on Strategic Review, Proposed Assets Disposal, Proposed Adoption of Investing Policy...
Realm Therapeutics Provides Update on Strategic Review PR Newswire MALVERN, Pa., Nov. 29, 2018 MALVERN, Pa., Nov. 29, 2018 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a...
Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process PR Newswire MALVERN, Pa., Sept. 17, 2018 MALVERN, Pa., Sept. 17, 2018...
Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results Company Hosting Conference Call Today at 9:00 AM ET / 2:00 PM...
Realm Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference PR Newswire MALVERN, Pa., Aug. 8, 2018 MALVERN, Pa., Aug. 8, 2018 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.